Details for New Drug Application (NDA): 019121
✉ Email this page to a colleague
NDA 019121 describes BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER, which is a drug marketed by B Braun, Baxter Hlthcare, and Hospira Inc, and is included in three NDAs. Additional details are available on the BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER profile page.
The generic ingredient in BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER is bretylium tosylate. There are three drug master file entries for this compound. Additional details are available on the bretylium tosylate profile page.
The generic ingredient in BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER is bretylium tosylate. There are three drug master file entries for this compound. Additional details are available on the bretylium tosylate profile page.
Summary for 019121
| Tradename: | BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER |
| Applicant: | B Braun |
| Ingredient: | bretylium tosylate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019121
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 100MG/100ML | ||||
| Approval Date: | Apr 29, 1986 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 200MG/100ML | ||||
| Approval Date: | Apr 29, 1986 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 400MG/100ML | ||||
| Approval Date: | Apr 29, 1986 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
